Lupin’s US arm receives the 2011 DIANA award

10 Jun 2011 Evaluate

Lupin’s subsidiary Lupin Pharmaceutical has received the 2011 DIANA award by the Healthcare Distribution Management Association (HDMA) for the best overall generic product manufacturing among those companies with the sale of up to $100 million in the healthcare distribution market.

HDMA distributor members selected the DIANA award winners to recognize companies that continually foster strong trading partner relationship with the Association’s primary distributor members by creating exceptional business practices that advance trade relationship and benefit the entire US healthcare supply chain.

Lupin is an innovation led transnational pharmaceutical company producing wide range of quality, affordable generic and branded formulations and API’s. Currently the company has significant presence in the cardiovascular, diabetology, asthma, pediatrics, CNS, CI, anti infective, NSAIDs addition to holding global leadership position in the anti TB and cephalosporins space.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×